Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 7/20 | 0.50 |
| ▸ | ANPEP | P15144 | 4/20 | 0.50 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.48 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27719619 | 1.00 | ENPEP (0.50) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL3358170 | 0.84 | DPP4 (0.51) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL3909782 | 0.84 | GRM8 (0.50) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL27584091 | 0.83 | GRM8 (0.47) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL30050502 | 0.82 | DPP4 (0.50) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL18285489 | 0.82 | DPP4 (0.50) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL28606931 | 0.82 | DPP4 (0.50) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL25246132 | 0.79 | DPP4 (0.47) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL18339143 | 0.79 | DPP4 (0.47) | ENPEPANPEPGRM8GRM6GRIN2D | |
| SCHEMBL10795389 | 0.79 | GSR (0.52) | GRM8GRM6GRIN2DGRIN3BGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118897023-B | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2025-03-25 | — | — | CN | claimed |
| US-6239111-B1 | DRUG FOR TREATING BRAIN DISEASES, ENABLES PREVENTION OR TREATMENT OF DEMENTIA AND SIMILAR DISEASES CAUSED BY DEGENERATION OR SLOUGHING OF NEURONS, AN ALLY SULFIDE, SULFOXIDE OR SULFONE | WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | claimed |
| EP-4097145-B1 | REDUCTION OF ADSORPTION | LEUKOCARE AG (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20250262258-A1 | MICROORGANISM WITH HIGH TRIPEPTIDE PRODUCTIVITY AND USE THEREOF | SAMYANG CORPORATION (KR) | 2025-08-21 | — | — | US | disclosed |
| US-20250255843-A1 | COMPOSITIONS COMPRISING CYSTEINE PRODRUGS AND METHODS USING THEREOF | Nature's Fusions, LLC | 2025-08-14 | — | — | US | disclosed |
| EP-4568653-A1 | COMPOSITIONS TO INCREASE GLUTATHIONE LEVELS AND PROCESSES FOR MAKING THE SAME | The ProImmune Company, LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| EP-4561372-A1 | COMPOSITIONS COMPRISING CYSTEINE PRODRUGS AND METHODS USING THEREOF | Nature's Fusions, LLC (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-117243971-B | Prefabricated nano enzyme and preparation method and application thereof | 郑州大学 | 2025-05-16 | — | — | CN | disclosed |
| CN-118897023-B | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2025-03-25 | — | — | CN | disclosed |
| CN-118897023-A | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2024-11-05 | — | — | CN | disclosed |
| CN-118829414-A | Composition for improving wrinkles comprising retinol enhancers as an active ingredient | 株式会社LG生活健康 | 2024-10-22 | — | — | CN | disclosed |
| EP-0869809-A1 | CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF | Balazovsky, Mark Borisovich (RU) | 1998-10-14 | — | — | EP | disclosed |
| EP-0848951-A1 | Use of acetylcysteine for the manufacture of a medicament for the treatment of chronic ulcers | Johnson & Johnson Medical Ltd. (GB) | 1998-06-24 | — | — | EP | disclosed |
| WO-1997021444-A9 | CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF | — | 1997-10-30 | — | — | WO | disclosed |
| WO-1997021444-A1 | CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF | BALAZOVSKY MARK BORISOVICH (RU) | 1997-06-19 | — | — | WO | disclosed |
| EP-0706655-A1 | MCA ASSAY/KIT FOR DETECTING METAL CATIONS | BIONEBRASKA, INC. (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0690709-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CERTAIN VIRUSES AND AUTOIMMUNE DISEASES AND THE PROCEDURE OF ITS PREPARATION | DINU, Constantin Romulus (RO) | 1996-01-10 | — | — | EP | disclosed |
| WO-1995000845-A1 | MCA ASSAY/KIT FOR DETECTING METAL CATIONS | BIONEBRASKA, INC. (US) | 1995-01-05 | — | — | WO | disclosed |
| WO-1994022438-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CERTAIN VIRUSES AND AUTOIMMUNE DISEASES AND THE PROCEDURE OF ITS PREPARATION | DINU CONSTANTIN ROMULUS (RO) | 1994-10-13 | — | — | WO | disclosed |
| US-4689347-A | CALCIUM SODIUM ETHYLENEDIAMINETETRAACETATE, CALCIUM GLUCONATE AND CYSTEINE | CENTRALA INDUSTRIALA DE MEDICAMENTE COSMETICE COLORANTI SI LACURI (RO) | 1987-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255843-A1 | COMPOSITIONS COMPRISING CYSTEINE PRODRUGS AND METHODS USING THEREOF | AHCY, MGMT, CBS | ENPEP 93/4885ANPEP 109/4885GRM8 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.